Michael Gelband’s Molina Healthcare MOH Stock Holding History

Michael Gelband’s Portfolio MOH Stock Details MOH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,035	Closed	-$1.2M	–	1910
2024 Q2	$1.2M	Buy	+4,035	New	+$1.37M	0.01%	955
2022 Q4	–	Sell	-14,084	Closed	-$4.64M	–	1943
2022 Q3	$4.64M	Sell	14,084 -674	-5%	-$217K	0.06%	427
2022 Q2	$4.13M	Buy	14,758 +8,250	+127%	+$2.49M	0.05%	473
2022 Q1	$2.17M	Sell	6,508 -6,513	-50%	-$2M	0.03%	735
2021 Q4	$4.14M	Buy	+13,021	New	+$3.87M	0.04%	506
2021 Q3	–	Sell	-5,070	Closed	-$1.28M	–	2443
2021 Q2	$1.28M	Buy	+5,070	New	+$1.27M	0.01%	874
2020 Q4	–	Sell	-8,924	Closed	-$1.63M	–	2222
2020 Q3	$1.63M	Buy	8,924 +2,227	+33%	+$405K	0.03%	470
2020 Q2	$1.19M	Buy	6,697 +2,086	+45%	+$355K	0.03%	655
2020 Q1	$644K	Buy	4,611 +1,402	+44%	+$188K	0.04%	410
2019 Q4	$435K	Sell	3,209 -2,722	-46%	-$343K	0.01%	944
2019 Q3	$651K	Buy	5,931 +988	+20%	+$128K	0.02%	544
2019 Q2	$708K	Buy	+4,943	New	+$677K	0.03%	360

Other funds holding MOH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Michael Gelband's MOH Position: Q3 2024 in Review

Michael Gelband sold out of Molina Healthcare (MOH) in Q3 2024, closing a stake of 4,035 shares — an estimated $1.2M sold.

Michael Gelband first reported a position in MOH in Q2 2019 and held it in 12 quarters. The position peaked at $4.64M in Q3 2022. 617 funds tracked by Wall St. Rank hold MOH as of Q3 2024.

Michael Gelband reported no remaining Molina Healthcare position as of Q3 2024 after selling out during the quarter.
Michael Gelband sold 4,035 Molina Healthcare shares in Q3 2024, an estimated $1.2M.
Michael Gelband first reported a position in Molina Healthcare in Q2 2019 and held it in 12 quarters.
Michael Gelband's Molina Healthcare position peaked at $4.64M in Q3 2022.
617 funds tracked by Wall St. Rank held Molina Healthcare as of Q3 2024.

Based on ExodusPoint Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.